« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6
, Pages 1409-1411
, June 2007
Translational research: Is there a future?
References
- Effects of pyridoxal-51-phosphate (cardoxal) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg. 2007;133:1604–1611
- . Evidence based medicine: how to practice and teach. 2nd ed.. London: Churchill-Livingston; 2000;
- . Disease-modifying therapy in MS: a critical review of the literature (Part I: analysis of clinical trial errors). J Neurol. 2004;251(Suppl 5):v3–v11
- . Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med. 1997;16:2529–2542
- . More powerful procedures for multiple significance testing. Stat Med. 1990;9:811–818
- Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA. 2004;291:2319–2327
- Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297:43–51
- . Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of terminal complement components and inhibition by anti-C5 therapy. Circulation. 1998;97:2259–2267
- . Injury research in the genomics era. Lancet. 2004;363:2076–2083
- . A vision for the future of genomics research. Nature. 2003;422:835–847
PII: S0022-5223(07)00294-2
doi: 10.1016/j.jtcvs.2007.01.048
© 2007 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6
, Pages 1409-1411
, June 2007
